CGC Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Hold
3,051
0.03% 86
2026
Q1
$191K Hold
3,051
0.06% 60
2025
Q4
$291K Hold
3,051
0.08% 52
2025
Q3
$298K Hold
3,051
0.08% 45
2025
Q2
$328K Hold
3,051
0.11% 38
2025
Q1
$308K Hold
3,051
0.12% 37
2024
Q4
$273K Hold
3,051
0.11% 43
2024
Q3
$256K Hold
3,051
0.1% 45
2024
Q2
$235K Hold
3,051
0.1% 44
2024
Q1
$209K Hold
3,051
0.11% 48
2023
Q4
$176K Hold
3,051
0.08% 58
2023
Q3
$161K Hold
3,051
0.11% 46
2023
Q2
$165K Buy
+3,051
New +$159K 0.11% 50

Other funds holding BSX

CGC Financial Services's BSX Position: Q2 2026 in Review

CGC Financial Services held its Boston Scientific (BSX) position steady in Q2 2026 at 3,051 shares worth $130K. The position accounts for 0.03% of the portfolio, ranked #86.

CGC Financial Services first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $328K in Q2 2025. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CGC Financial Services held 3,051 shares of Boston Scientific worth $130K as of Q2 2026.
  • CGC Financial Services left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.03% of CGC Financial Services's portfolio in Q2 2026, its #86 holding.
  • CGC Financial Services first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • CGC Financial Services's Boston Scientific position peaked at $328K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CGC Financial Services's 13F filing for Q2 2026, filed 13 Jul 2026.